Medical AI Alliance
← Company Index
Medical DevicesKOSDAQ 3769004 approvals

ROKIT HEALTHCARE Inc.

Official website

KOSDAQ-listed medical device company with an organ regeneration platform expanding from diabetic foot skin regeneration into cartilage and kidney regeneration.

As of 2026-10-10, ROKIT HEALTHCARE Inc. has 4 Korean MFDS device approvals, 13 PubMed-indexed papers on record (counted by the MAA Company Index from its own matching of public databases).

Price

Change

Market cap

Business overview

Source: DART corporate disclosure

Founded in 2012 and listed on KOSDAQ in 2025, ROKIT HEALTHCARE is a company specializing in an organ regeneration platform. It is expanding its skin regeneration platform, centered on diabetic foot treatment, into pressure ulcers, burns, traumatic defects, post-skin-cancer-excision defects, and breast reconstruction, while conducting preclinical, clinical, and joint research in cartilage and kidney regeneration. It has obtained ISO13485 (2019), KGMP (2023), CE MDR (2023), and U.S. FDA (2023) certifications, and has signed skin regeneration platform contracts with LABORATOIRE BENEWMEDICAL and others, and cartilage regeneration platform contracts with Bioethic Pharma S.A and others.

Products & technology

  • Skin regeneration platformSkin regeneration treatment for diabetic foot, pressure ulcers, burns, traumatic defects, post-skin-cancer-excision defects, and breast reconstruction
  • Cartilage regeneration platformCartilage regeneration treatment
  • Kidney regeneration platformKidney regeneration treatment

Regulatory approvals

data.go.kr

4 Korean MFDS device approvals · 2020–2023

  • MFDSFat separator, filter2023-01-05
    Product approval · Class 3제허 23-9 호
  • MFDSPerimeter, automaticRevoked2021-08-19
    Product approval · Class 1수신 21-1580 호
  • MFDSFat separator, filter2021-03-30
    Product approval · Class 3제허 21-206 호
  • MFDSHuman cell ＆ Tissue culture incubator2020-01-20
    Product approval · Class 1체외 제신 20-86 호

Global clinical trials

ClinicalTrials.gov · sponsor-matched

R&D and key agreements

Source: DART corporate disclosure

연골재생 및 신장재생 전임상·임상 공동연구 · 연골, 신장 · 전임상·임상 진행중 · 5-person technology research institute conducting clinical work and organ regeneration protocol development for skin, cartilage, and kidney regeneration

Publications

PubMed · affiliation-matched
Show 3 more publications

Patents

KIPRIS · applicant-matched
Show 117 more patents

AI reads

MAA server logs · IP-verified
69
Times AI engines pulled ROKIT HEALTHCARE Inc.'s records

Pulled records become part of each AI's index and keep feeding its answers. When an AI cites from that index, nothing reaches our server — so actual citations are uncounted here and exceed this number.

0
Fetched fresh mid-answer

Times an AI needed something not yet in its index and fetched this page fresh while answering. Citations served from the index leave no trace here.

69
Index crawls

Collected as raw material for future answers.

0
Direct AI-tool queries (MCP)

Queries from users who connected this index to their own AI.

12
live 0
Last 7 days
58
live 0
Last 30 days
69
live 0
All time
  • OpenAIOAI-SearchBot61
  • PerplexityPerplexityBot3
  • GoogleGoogleOther2
  • AnthropicClaudeBot2
  • MicrosoftBingbot1

Measured since Aug 27, 2026 · 5 AI engines · last read Oct 9, 2026

User-agent strings can be forged, so we do not count them at face value. We count only requests matched against vendor-published IP ranges, or confirmed by forward-verified reverse DNS. MCP queries are actual calls to this index's tool endpoint.

Connect this index to your AI tool →

Connect this company index directly to your AI

Connect it to ChatGPT or Claude, and your AI queries the full record — profiles, financials, stock data, regulatory approvals, clinical trials, publications and patents — for ROKIT HEALTHCARE Inc. and every listed Korean medical, bio and AI company.

How to connect (MCP)
Not yet compiled: business overview. Send us materials and we will add them

Companies approved for the same productsMedical Devices

Ranked by how many MFDS product categories overlap. Not a ranking — a pointer to where to look.

CELLUMED CO., LTD.1 shared

KOSDAQ-listed holding company making medical devices and biologics including bone graft rhBMP2 and knee implant TKR.

Chabiotech Co.,Ltd.1 shared

Cord blood storage and cell therapy company that has expanded into global CDMO manufacturing and overseas medical network services.

Huvitz Co., Ltd.1 shared

KOSDAQ-listed medical device company producing auto refractors, auto lensmeters, and other ophthalmic equipment.

INTEROJO CO. LTD.100

Interojo, founded 2000 and KOSDAQ-listed 2010, manufactures contact lenses under its Clalen brand domestically and via OEM/ODM overseas.

MITECH CO.,LTD.100

MITECH CO.,LTD., founded in 1991 and listed on KOSDAQ in 2018, makes non-vascular stents and distributes Fujifilm endoscopy equipment.

JETEMA Co.,Ltd.90

Founded 2009, listed on KOSDAQ in 2019, JETEMA develops hyaluronic acid fillers, botulinum toxin biopharmaceuticals, and lifting threads.

Corentec Co., Ltd.85

Founded in 2000 and KOSDAQ-listed in 2013, Corentec makes artificial joints; hip and knee implants exceed 85% of revenue.

NanoenTek,Inc.85

Founded in 1987 and listed on KOSDAQ in 2000, NanoenTek develops Lab-On-a-Chip in-vitro diagnostic devices and life science instruments.

SEJONG MEDICAL Co.Ltd.,85

Founded in 2010 and KOSDAQ-listed in 2018, Sejong Medical manufactures laparoscopic surgical instruments.

REMEDI Inc.85

Founded in 2012 and listed on KOSDAQ in 2026, REMEDI develops portable X-ray imaging devices based on its low-dose, miniaturized X-ray technology.

Laseroptek Co., Ltd.85

KOSDAQ-listed medical device company developing the LOTUS and HELIOS laser aesthetic devices and the PALLAS vitiligo treatment device.

AIOBIO Co., Ltd.85

Develops quantitative fluorescence biomarker technology for oral disease diagnostic devices.

Sources and updates

Counts on this page are not company-reported figures. MAA matched records from DART, the Korean MFDS, the US FDA, ClinicalTrials.gov, PubMed and KIPRIS to this company itself, by business registration number or registered name, never by name similarity. They may differ from figures the company publishes.

Company basics
Korea Exchange · DART
Business content
Compiled from disclosure filings
Approvals & clinical trials
Korean MFDS (data.go.kr) · US FDA openFDA — updated weekly
Key disclosures
KRX KIND via OpenDART exchange filings — updated daily
Global clinical trials
ClinicalTrials.gov (US NIH) — sponsor-matched, updated weekly
Financials
DART corporate disclosure filings — annual
Publications
PubMed (US National Library of Medicine) — affiliation-matched, updated daily
Patents
KIPRIS (Korea Institute of Patent Information) — applicant-matched, updated monthly
AI reads
Our server logs, IP-verified every 6 hours
AI visibility
Measured 2026-10-01

This page is compiled from public sources without the company's involvement. If anything is inaccurate or incomplete, please let us know. Materials provided by the company are labelled as such.

Request a correction or addition